Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Netherlands
Clinical trial register · Netherlands

Clinical Trials in the Netherlands

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3174 matching records held by the registry are in this view. Synced 16 Nov 2026, 03:18 UTC
3174
Studies in scope
all four open statuses
1791
Recruiting now
open to new participants
602
Lead sponsors
across recruiting studies
Top sites
's-Hertogenbosch 1 Alkmaar 1 Almere Stad 1 Amsterdam 1 Apeldoorn 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Erasmus Medical Center152 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)132 University Medical Center Groningen132 Radboud University Medical Center109 AstraZeneca87 Maastricht University Medical Center81 Leiden University Medical Center77 Novartis Pharmaceuticals76 The Netherlands Cancer Institute71 UMC Utrecht65 Merck Sharp & Dohme LLC63 Janssen Research & Development, LLC61 Amsterdam UMC, location VUmc60 Eli Lilly and Company45 Boehringer Ingelheim37 AbbVie35 Sanofi34 Bristol-Myers Squibb33 Hoffmann-La Roche30 GlaxoSmithKline27 Novo Nordisk A/S25 Pfizer24 Amgen24 European Organisation for Research and Treatment of Cancer - EORTC22 St. Antonius Hospital22 Stichting Hemato-Oncologie voor Volwassenen Nederland21 Maastricht Radiation Oncology17 Genmab16 Daiichi Sankyo16 Bayer16 Incyte Corporation16 Wageningen University16 Abbott Medical Devices15 argenx14 Takeda14 Rijnstate Hospital14 Vertex Pharmaceuticals Incorporated13 Boston Scientific Corporation12 Princess Maxima Center for Pediatric Oncology12 Catharina Ziekenhuis Eindhoven11 Franciscus Gasthuis11 Zuyderland Medisch Centrum11 Alnylam Pharmaceuticals11 Gilead Sciences9 Regeneron Pharmaceuticals9 Medisch Spectrum Twente9 Maxima Medical Center9 Exelixis8 JointResearch8 Celgene8 Seagen, a wholly owned subsidiary of Pfizer8 W.L.Gore & Associates8 Alexion Pharmaceuticals, Inc.8 University Hospital, Basel, Switzerland8 Amsterdam UMC8 Universitaire Ziekenhuizen KU Leuven7 Maastricht University7 Ionis Pharmaceuticals, Inc.7 AO Innovation Translation Center7 Medtronic Cardiovascular7 Agios Pharmaceuticals, Inc.7 BeOne Medicines7 Tilburg University6 Zimmer Biomet6 European Myeloma Network B.V.6 Mirati Therapeutics Inc.6 Institut de Recherches Internationales Servier6 Universiteit Leiden6 Reinier Haga Orthopedisch Centrum6 Astellas Pharma Global Development, Inc.6 Sint Maartenskliniek6 VU University of Amsterdam6 Revolution Medicines, Inc.5 Biogen5 Genentech, Inc.5 Gustave Roussy, Cancer Campus, Grand Paris5 University of Twente5 Deciphera Pharmaceuticals, LLC5 Jasper Gerritsen5 University of Amsterdam5 Ultragenyx Pharmaceutical Inc5 Medtronic5 Population Health Research Institute5 Denali Therapeutics Inc.5 Washington University School of Medicine5 ModernaTX, Inc.5 Isala5 Vascutek Ltd.5 ETOP IBCSG Partners Foundation5 University of Birmingham5 Copenhagen University Hospital, Rigshospitalet4 De Viersprong4 Kite, A Gilead Company4 M.A. Med Alliance S.A.4 Spaarne Gasthuis4 Edwards Lifesciences4 Intellia Therapeutics4 Alkermes, Inc.4 Oslo University Hospital4 Haaglanden Medical Centre4 Institut National de la Santé Et de la Recherche Médicale, France4 Italfarmaco4 ViiV Healthcare4 UNICANCER4 CSL Behring4 Aragon Pharmaceuticals, Inc.4 University of Oxford4 Acerta Pharma BV4 Borstkanker Onderzoek Groep4 Jaeb Center for Health Research4 Pierre Fabre Medicament4 Stichting European Myeloma Network3 Blueprint Medicines Corporation3 Philips Clinical & Medical Affairs Global3 Corsano Health B.V.3 Universitair Ziekenhuis Brussel3 BioNTech SE3 DePuy Orthopaedics3 Xenon Pharmaceuticals Inc.3 Miltenyi Biomedicine GmbH3 Insel Gruppe AG, University Hospital Bern3 Basilea Pharmaceutica3 Cathreine BV3 The Hospital for Sick Children3 Nutricia Research3 Academisch Ziekenhuis Maastricht3 Martini Hospital Groningen3 Alfasigma S.p.A.3 Institut für Pharmakologie und Präventive Medizin3 Assistance Publique - Hôpitaux de Paris3 IRCCS San Raffaele3 Roessingh Research and Development3 IDEAYA Biosciences3 Zealand Pharma3 Mirum Pharmaceuticals, Inc.3 Nuvalent Inc.3 ARQ National Psychotrauma Centre3 Comprehensive Cancer Centre The Netherlands3 University Hospital, Ghent3 EMD Serono Research & Development Institute, Inc.3 Genzyme, a Sanofi Company3 Karyopharm Therapeutics Inc3 University of Zurich3 Universitätsklinikum Hamburg-Eppendorf3 Cogent Biosciences, Inc.3 Medtronic Cardiac Surgery3 Leiden University3 Charite University, Berlin, Germany3 University Medical Center Nijmegen3 Memorial Sloan Kettering Cancer Center3 GRIN Therapeutics, Inc.3 Karakter Kinder- en Jeugdpsychiatrie3 Dianthus Therapeutics3 Reinier de Graaf Groep3 Vrije Universiteit Brussel3 Ggz Oost Brabant3 Avidity Biosciences, Inc.3 ReCor Medical, Inc.3 TripleMed B.V.3 Otsuka Pharmaceutical Development & Commercialization, Inc.3 JOTEC GmbH3 HAN University of Applied Sciences2 ITM Solucin GmbH2 Astria Therapeutics, Inc.2 Thomas Jefferson University2 dr. Laura C. G. de Graaff-Herder2 Olema Pharmaceuticals, Inc.2 Ataxia Study Group2 Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2 Syndax Pharmaceuticals2 University of Groningen2 University of Pennsylvania2 Wageningen University and Research2 BioMarin Pharmaceutical2 University of Cologne2 ML Bio Solutions, Inc.2 Jeroen van Eijk2 Albireo, an Ipsen Company2 Daniel Keszthelyi2 CoreAalst BV2 Longboard Pharmaceuticals2 Rigel Pharmaceuticals2 DBV Technologies2 R&D Cardiologie2 Bart Koes2 MicroPort CRM2 Enliven Therapeutics2 Indiana University2 ArriVent BioPharma, Inc.2 Cochlear2 Alliance for Clinical Trials in Oncology2 Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)2 USWM CT, LLC2 Pharming Technologies B.V.2 PedAL BCU, LLC2 Prilenia2 Sahlgrenska University Hospital2 Frisius Medisch Centrum2 Jord Vink2 Albert Schweitzer Ziekenhuis, Netherlands2 Accare2 ALX Oncology Inc.2 University of Aarhus2 Behavioural Science Institute2 Medtronic Vascular2 Merit Medical Systems, Inc.2 CUTISS AG2 Onze Lieve Vrouwe Gasthuis2 Kardigan, Inc.2 Amicus Therapeutics2 Salvia BioElectronics2 Celldex Therapeutics2 Alimentiv Inc.2 Meril Life Sciences Pvt. Ltd.2 Immunocore Ltd2 University Hospital, Gasthuisberg2 Tesaro, Inc.2 Stemline Therapeutics, Inc.2 Servier Affaires Médicales2 CVRx, Inc.2 Loxo Oncology, Inc.2 AC Immune SA2 Centre for Human Drug Research, Netherlands2 Michael J. Fox Foundation for Parkinson's Research2 Chugai Pharmaceutical2 dr. M.J.N.L. Benders2 Calico Life Sciences LLC2 Biohaven Therapeutics Ltd.2 Vertero Therapeutics2 Dyne Therapeutics2 Vir Biotechnology, Inc.2 University of Ulm2 Laboratoires Thea2 Iovance Biotherapeutics, Inc.2 European Clinical Research Alliance for Infectious Diseases (ECRAID)2 Neurocrine Biosciences2 Taiho Oncology, Inc.2 Parnassia Groep2 Children's Oncology Group2 Utrecht University2 Byondis B.V.2 Medtronic Cardiac Ablation Solutions2 Geestelijke Gezondheidszorg Eindhoven (GGzE)2 Weill Medical College of Cornell University2 Imricor Medical Systems2 NewAmsterdam Pharma2 Parnassia Addiction Research Centre2 Abivax S.A.2 Scholar Rock, Inc.2 Entrada Therapeutics, Inc.2 Cytokinetics2 Vastra Gotaland Region2 University of Kansas Medical Center2 Crinetics Pharmaceuticals Inc.2 Camurus AB2 Alzheimercentrum Amsterdam2 United Therapeutics2 Avalyn Pharma Inc.2 Santen SAS2 Day One Biopharmaceuticals, Inc.2 Region Skane2 Mediar Therapeutics2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Medtronic MiniMed, Inc.2 Creo Medical Limited2 Viridian Therapeutics, Inc.2 Nationwide Children's Hospital2 MedImmune LLC2 Telix Pharmaceuticals (Innovations) Pty Limited2 Arcus Biosciences, Inc.2 Jennifer Breel2 Isabelle Henskens2 M.R. Meijerink2 Immunovant Sciences GmbH2 University Hospital, Geneva2 University Hospital, Antwerp2 Vaderis Therapeutics AG2 Deventer Ziekenhuis2 Meander Medical Center2 Corcept Therapeutics2 Shape Memory Medical, Inc.2 Istituto Giannina Gaslini2 Janssen Pharmaceutica N.V., Belgium2 Jazz Pharmaceuticals2 Canisius-Wilhelmina Hospital2 Pulmair Medical, Inc.2 Galvani Bioelectronics2 Calcilytix Therapeutics, Inc., a BridgeBio company2 Haukeland University Hospital2 Arkin2 General Practitioners Research Institute2 Apreo Health, Inc.2 Eidos Therapeutics, a BridgeBio company2 Verastem, Inc.2 Pharvaris Netherlands B.V.2 Tergooi Medical Center2 Inhibrx Biosciences, Inc2 Hospital Universitari Vall d'Hebron Research Institute2 Dr. Mark Mulder2 Apellis Pharmaceuticals, Inc.2 The Leeds Teaching Hospitals NHS Trust1 University of Liege1 University of Exeter1 Roxanne Gal1 NVT GmbH1 VDI Technologies1 Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)1 Willeke Boonstra1 NeuroDerm Ltd.1 Hansa Biopharma AB1 Incyte Biosciences International Sàrl1 Hemab ApS1 MoonLake Immunotherapeutics AG1 HagaZiekenhuis1 Amsterdam University of Applied Sciences1 Zenas BioPharma (USA), LLC1 Pulmonx Corporation1 Erik de Loos1 Chalmers University of Technology1 Icahn School of Medicine at Mount Sinai1 Acesion Pharma1 RyCarma Therapeutics, Inc.1 Anocca AB1 Aura Biosciences1 Diagram B.V.1 Kyowa Kirin Pharmaceutical Development Ltd1 ProJenX1 Veerle Ruijters1 University of Virginia1 Translumina Therapeutics Pvt Ltd.1 PDC*line Pharma SAS1 Rapamycin Holdings Inc.1 Protagonist Therapeutics, Inc.1 Norwegian University of Science and Technology1 QurAlis Corporation1 University Hospital Heidelberg1 Noah Labs1 University of Washington1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 Aleksander Krag1 Amber Therapeutics Ltd1 Matt Harmon1 Jubaan Ltd.1 Australia and New Zealand Sarcoma Association1 Helsinki University Central Hospital1 Terumo Europe N.V.1 IO Biotech1 Angitia Incorporated Limited1 Janneke van de Wijgert1 Universitat Internacional de Catalunya1 Unity Health Toronto1 Koen Rovers1 European Association of Urology Research Foundation1 Annemie Spooren1 Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 JCR Pharmaceuticals Co., Ltd.1 Tobias Feuchtinger1 Tessera Therapeutics, Inc.1 Matthijs de Hoog1 Zaandam Medical Center1 Drahomir Aujesky1 Neuspera Medical, Inc.1 Imbria Pharmaceuticals, Inc.1 Leal Therapeutics, Inc1 ARH van Zanten, MD PhD1 Sangamo Therapeutics1 SPCTR1 Cortex1 POROUS GmbH1 Joachim Aerts, MD PhD1 International Extranodal Lymphoma Study Group (IELSG)1 DeuterOncology1 McMaster University1 CeleCor Therapeutics1 Mats Heyman1 Fundació d'investigació Sanitària de les Illes Balears1 Smith & Nephew Orthopaedics AG1 Denzel Drop1 Baxalta now part of Shire1 CarThera1 KU Leuven1 Bioverativ, a Sanofi company1 Science Corporation1 Surgimab1 Shanghai Junshi Bioscience Co., Ltd.1 Centre Leon Berard1 Children's Hospital of Philadelphia1 Almirall, S.A.1 Mara Veenstra, MD1 Maasstad Hospital1 Tristan Buck1 Mark C Burgmans, MD PhD1 R.Bos1 Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd1 Prof. Dr. Folkert W. Asselbergs1 Rocket Pharmaceuticals Inc.1 Franciscus Gasthuis & Vlietland (Hospital)1 M.G. Besselink1 M. Medici1 The European Forum for Research and Education in Allergy and Airway Diseases1 St. Anna Kinderkrebsforschung1 Biotronik AG1 OHB Neonatology Ltd.1 Sabine Mueller, MD, PhD1 Partner Therapeutics, Inc.1 NEAT ID Foundation1 Dompé Farmaceutici S.p.A1 Prospective Bladder Cancer Infrastructure Foundation1 St. Olavs Hospital1 EBI Anti Sepsis BV1 Hasselt University1 Associazione Italiana Ematologia Oncologia Pediatrica1 Mundipharma Research Limited1 SecuraBio1 RECORDATI GROUP1 Michele van Vugt1 Cook Research Incorporated1 Grey Wolf Therapeutics1 Respicardia, Inc.1 VDyne, Inc.1 Linda Douw1 University of Massachusetts, Worcester1 LEO Pharma1 Copenhagen Trial Unit, Center for Clinical Intervention Research1 Generate Biomedicines1 OncoC4, Inc.1 Santhera Pharmaceuticals1 M.D. Anderson Cancer Center1 Olatec Therapeutics, Inc.1 Blue Earth Diagnostics1 Weizmann Institute of Science1 Fundacio Puigvert1 Friedreich's Ataxia Research Alliance1 Denise van Diermen1 Newcastle University1 Materialise1 Rutger Lalieu1 NovoCure Ltd.1 Majanka H. Heijenbrok-Kal, PhD1 MaaT Pharma1 Centre hospitalier de l'Université de Montréal (CHUM)1 RHEACELL GmbH & Co. KG1 Claudia Schuurhuizen1 Anders Perner1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 VZW Cardiovascular Research Center Aalst1 J.P.S Henriques1 Ryme Medical, Inc.1 Uppsala University1 ProQR Therapeutics1 Heidelberg University1 Promedius Inc1 Occlutech International AB1 J. W. A. Burger1 Spark Therapeutics, Inc.1 VectivBio AG1 Dijklander Ziekenhuis1 Vall d'Hebron Institute of Oncology1 Curadel Surgical Innovations, Inc.1 AtaCor Medical, Inc.1 Verve Therapeutics, Inc.1 Janine M. Simons MD PhD1 RayzeBio, Inc.1 Molecure S.A.1 Vector Y Therapeutics1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Orthopedisch Centrum Oost Nederland1 Biohaven Pharmaceuticals, Inc.1 University College, London1 Medtronic - MITG1 JenaValve Technology, Inc.1 Marjolein Spiering1 Azienda Ospedaliero-Universitaria Careggi1 Abraham Hulst, MD, PhD1 Flevoziekenhuis1 Willem de Haan1 Morair Medtech, LLC1 German CLL Study Group1 Solstice Oncology, Inc.1 E.S.stroes1 Actelion1 Genetix Biotherapeutics Inc.1 Prof. Jan Prins1 SynOx Therapeutics Limited1 Wim Janssens1 Axonics, Inc.1 Vividion Therapeutics, Inc.1 Beam Therapeutics Inc.1 The University of Queensland1 Rhythm Pharmaceuticals, Inc.1 Casper Rokx1 Murdoch Childrens Research Institute1 Ziekenhuisgroep Twente1 AIRNA Corporation1 Koen Munters1 Medical University of Graz1 Coloplast A/S1 EBR Systems, Inc.1 Citryll BV1 Pulmovant, Inc.1 Gabriel Riva1 AVEO Pharmaceuticals, Inc.1 Disc Medicine, Inc1 Vivalyx GmbH1 David Palma1 Uniquity One (UNI)1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Dimitri Diavatopoulos1 Frank G. Holz1 Princess Amalia Children's Clinic1 Oticon Medical1 Philipp Homan1 PROspective Renal Cancer Cohort Foundation1 AskBio Inc1 Maria Joyera Rodríguez1 Centre Hospitalier Universitaire de Nice1 PharmaMar1 AviadoBio Ltd1 Penn State University1 Endospan Ltd.1 Davy van de Sande1 BioNTech Cell & Gene Therapies GmbH1 BioAegis Therapeutics Inc.1 VieCuri Medical Centre1 CatalYm GmbH1 XVIVO Perfusion1 C.H. van Gils1 Christiaan Vinkers1 invoX Pharma Limited1 BrioHealth BV1 Goed Medisch Centrum1 GGZ Centraal1 XEOS Medical1 ARCAGY/ GINECO GROUP1 Blue Earth Therapeutics Ltd1 Immunome, Inc.1 ABX advanced biochemical compounds GmbH1 AvenCell Europe GmbH1 A.J.C. Slooter1 Matthias Stuber1 Ellipses Pharma1 Jakob Stenman1 Cardurion Pharmaceuticals, Inc.1 Steffen Paschen1 Philipp Dutkowski1 University of Leeds1 Nerviano Medical Sciences1 Institut Straumann AG1 Biogem s.c.ar.l.1 AriBio Co., Ltd.1 Nyxoah S.A.1 Ludwig-Maximilians - University of Munich1 Amsterdam University Medical Center1 Replasia BV1 Liselot Ribbert1 Poitiers University Hospital1 Toronto Metropolitan University1 Fundación EPIC1 113 Suicide Prevention1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Ole De Backer1 Omeros Corporation1 Zoll Medical Corporation1 Atos Medical AB1 European Society of Cardiology1 Sarepta Therapeutics, Inc.1 Next Biomedical Co., Ltd.1 Dentsply Sirona Implants and Consumables1 Universität Münster1 Shionogi1 dr.Frank L.J. Visseren1 Centauri Therapeutics Limited1 Zydus Therapeutics Inc.1 LMU Klinikum1 IntraBio Inc1 Azalea Vision1 University Hospital Tuebingen1 Annexon, Inc.1 UCB Biopharma SRL1 Ivy Brain Tumor Center1 Fondazione Ricerca e Innovazione Cardiovascolare ETS1 VarmX B.V.1 Bolt Medical1 Foundry Innovation & Research 1, Limited (FIRE1)1 Cardiawave SA1 Ottawa Heart Institute Research Corporation1 Genethon1 Mitera Hospital1 Jeroen Bosch Ziekenhuis1 Alentis Therapeutics AG1 Immatics Biotechnologies GmbH1 Fontys University of Applied Sciences1 Nick Beije1 BioCryst Pharmaceuticals1 Academisch Medisch Centrum - Amsterdam UMC Research BV1 Cyril Camaro1 Mark van Loo1 Tanabe Pharma America, Inc.1 Gossamer Bio USA, Inc.1 Neurosoft Bioelectronics SA1 Mattienne van der Kamp1 Essilor International1 Tyra Biosciences, Inc1 Profound Medical Inc.1 Zogenix, Inc.1 Research Maatschap Cardiologen Rotterdam Zuid1 University of Calgary1 ARTHEx Biotech S.L.1 Idoven 1903 S.L.1 Inhibikase Therapeutics1 Ipsen1 Gynaecologisch Oncologisch Centrum Zuid1 Jip Groen1 Therini Bio, Inc.1 Rare Thyroid Therapeutics International AB1 Arga Medtech SA1 University of Edinburgh1 Henrik Endeman1 FCRE (Foundation for Cardiovascular Research and Education)1 Ancora Heart, Inc.1 Viatris Innovation GmbH1 Wetenschappelijk Onderzoek en Datacentrum1 Bethesda Diabetes Research Center1 Kumquat Biosciences Inc.1 MRIguidance B.V.1 Nurix Therapeutics, Inc.1 Christian Dorfer1 BioProtect1 Fore Biotherapeutics1 Prof. Valérie Mc Lin1 Heike M.U. Peulen1 Association NVALT Studies1 University Hospital Muenster1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 ATRO Medical B.V.1 Sahajanand Medical Technologies Limited1 Orchestra BioMed, Inc1 Amphia Hospital1 Clinica Universidad de Navarra, Universidad de Navarra1 Xcovery Holdings, Inc.1 Janssen Scientific Affairs, LLC1 Stanford University1 Trace Neuroscience, Inc.1 Rotkreuzklinikum München gGmbH1 Nyika D. Kruyt1 Shanghai MicroPort Medical (Group) Co., Ltd.1 Biosense Webster, Inc.1 COMPASS Pathways1 Saluda Medical Pty Ltd1 University of California, Los Angeles1 Nantes University Hospital1 National University of Ireland, Galway, Ireland1 Corvia Medical1 Inspire Medical Systems, Inc.1 Micro Medical Solution, Inc.1 Actuate Therapeutics Inc.1 Exactech1 Nuvaira, Inc.1 Immatics US, Inc.1 University of Leicester1 Bordeaux Colorectal Institute Academy1 Eisai Inc.1 Nura Bio1 Jasper Brugts MD PhD1 MeiraGTx Ocular UK Ltd1 Luuk Stapersma1 Alliance Foundation Trials, LLC.1 Dutch Colorectal Cancer Group1 dr. Tom van der Hulle1 Inventiva Pharma1 4TEEN4 Pharmaceuticals GmbH1 Candela Corporation1 Electra Therapeutics Inc.1 Institute of Cancer Research, United Kingdom1 Altrecht1 Netherlands Heart Institute1 European LeukemiaNet1 University of Glasgow1 EP Solutions SA1 A.J.M. van den Eertwegh1 Advanced Accelerator Applications1 Marieke Duiverman1 Pulse Biosciences, Inc.1 Lakefront Biotherapeutics NV1 Penumbra Inc.1 Duke University1 Erasmus University Rotterdam1 Travere Therapeutics, Inc.1 Janssen-Cilag International NV1 CAMP4 Therapeutics Corporation1 Stereotaxis1 JL Tol1 Abby Geerlings1 Calluna Pharma AS1 Johns Hopkins University1 Senz1 AnaptysBio, Inc.1 Mariette Boshuis1 European Foundation for Study of Chronic Liver Failure1 Gelre Hospitals1 InnoCon Medical1 Balt Extrusion1 Professor Monique A. H. Steegers1 Grifols Therapeutics LLC1 The POLG Foundation1 Lmito Therapeutics Inc.1 Neurimmune AG1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Society of Interventional Oncology1 Melanoma and Skin Cancer Trials Limited1 Marc van Sambeek1 Zai Lab (Shanghai) Co., Ltd.1 CHDI Foundation, Inc.1 GGZ Friesland1 University of Turku1 J.M. ten Berg1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 Hidde van der Ploeg1 Vivasure Medical Limited1 Atrial Fibrillation Network1 Aarhus University Hospital1 Anne Voor in 't holt1 Prevail Therapeutics1 Vitestro B.V.1 Vesalio1 Biotronik SE & Co. KG1 Javier P. Gisbert1 GLSMED Learning Health S.A.1 Erasca, Inc.1 Lucid Diagnostics, Inc.1 Milestone Pharmaceuticals Inc.1 Elios Vision, Inc.1 Epics Therapeutics1 University of Roma La Sapienza1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 ReCode Therapeutics1 Massachusetts General Hospital1 Vico Therapeutics B. V.1 AtriCure, Inc.1 Eduard Verheijen1 Delcath Systems Inc.1 Zimmer, GmbH1 Magnus Nilsson1 Sirius Medical Systems B.V.1 Vedanta Biosciences, Inc.1 Klimmendaal Revalidatiespecialisten1 SymBio Pharmaceuticals1 Marc Bosiers, MD1 V-Wave Ltd1 Abiomed Inc.1 Taewoong Medical Co., Ltd.1 St. Anna Ziekenhuis, Geldrop, Netherlands1 University Hospital, Tours1 Prof. Dr. Remi A. Nout1 Rede Optimus Hospitalar SA1 EuroBloodNet Association1 Buda Health Center1 Julius Clinical1 J.M. de Laat1 Norgine1 Morten H. Bestle1 Geron Corporation1 Van Creveldkliniek1 Maartje van den Belt1 Algernon Pharmaceuticals1 Instituto de Investigación Biomédica de Salamanca1 Cullinan Therapeutics Inc.1 NS Pharma, Inc.1 University of California, San Francisco1 Stichting Reade1 Rezolute1 Corcym S.r.l1 Aarhus University Hospital Skejby1 Semmelweis University1 NovoCure GmbH1 University of Leipzig1 Portsmouth Hospitals NHS Trust1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 Marieke Goodijk1 Servier Bio-Innovation LLC1 The Lowy Medical Research Institute Limited1 Meyer Children's Hospital IRCCS1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 PedNet Haemophilia Research Foundation1 srdpiers1 dr Pim A.L. Tonino1 Groupe SEBBIN1 Natasha Appelman-Dijkstra1 Nobel Biocare1 Eske Kvanner Aasvang1 Turning Point Therapeutics, Inc.1 Johnson & Johnson Enterprise Innovation Inc.1 ProPersona1 Bart Rijnders1 Cardiovascular Research Foundation, New York1 NMD Pharma A/S1 VahatiCor, Inc.1 Virginia Commonwealth University1 ORNND - Operating Room Nurse Network Denmark1 NHS Greater Glasgow and Clyde1 Diakonessenhuis, Utrecht1 Shanghai Henlius Biotech1 Iris Plug1 Italian Sarcoma Group1 AgNovos Healthcare, LLC1 Park Medical centrum1 Integrum1 Cambridge University Hospitals NHS Foundation Trust1 ADC Therapeutics S.A.1 Savara Inc.1 Change Accelerator in Respiratory Care1 dr. P. Noordzij1 AMT Medical BV1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Marta Marciniak1 Iambic Therapeutics, Inc1 IRCCS Sacro Cuore Don Calabria di Negrar1 Var2 Pharmaceuticals1 SECRETO Study Consortium1 GGZ Noord-Holland-Noord1 Royal Dutch Visio1 KANDO Research1 University of Melbourne1 Eupraxia Pharmaceuticals Inc.1 Philippe ROUSSELOT1 Khondrion BV1 eleva GmbH1 POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company1 University of Applied Sciences Utrecht1 NYU Langone Health1 Gelderse Vallei Hospital1 Smith & Nephew, Inc.1 University of Kiel1 Britannia Pharmaceuticals Ltd.1 iVascular S.L.U.1 TransThera Sciences (Nanjing), Inc.1 ABLE Human Motion S.L.1 Medical University of Vienna1 Nick van der Beek1 OSE Immunotherapeutics1 Happitech BV1 Proctos Kliniek1 MedSIR1 Bas P. L. Wijnhoven1 Beyond Batten Disease Foundation1 Shockwave Medical, Inc.1 Dr. G.H. (Henrike) Westerveld1 Mineralys Therapeutics Inc.1 Jos M. A. Kuijlen1 Valérie Schuermans1 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1 Idris Bahce1 Prof. Dr. Martin Wabitsch1 M. Rienstra1 Edgewise Therapeutics, Inc.1 Joost J. M. E. Nuyttens1 Carmen Dietvorst1 Orchard Therapeutics1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 Abbisko Therapeutics Co, Ltd1 Marc van Det1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Göteborg University1 Niek Wijnen1 University of Utah1 Biotronik, Inc.1 University Hospital, Essen1 Martin Huelsmann1 Ziekenhuis Oost-Limburg1 Albert Schweitzer Hospital1 Angela HUTTNER1 Dutch Society of Physicians for Pulmonology and Tuberculosis1 Relay Therapeutics, Inc.1 Robovision BV1 Christian S. Meyhoff1 Galderma R&D1 D.J. (Dirk) Grünhagen1 King's College Hospital NHS Trust1 Hanneke W. M. van Laarhoven1 Canadian Cancer Trials Group1 Hamilton Health Sciences Corporation1 Janssen-Cilag Ltd.1 GEN İlaç ve Sağlık Ürünleri A.Ş.1 Clear sponsor filter
Target enrolment
to

Trials in this register

1 of 3174 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
NO Re-excision MelanomA - NORMA 2
NCT07530887Melanoma (Skin Cancer)
Marieke Goodijk
Phase 3
1,749
's-Hertogenbosch, Alkmaar, Almere Stad, Amsterdam, Apeldoorn, Arnhem, Eindhoven, Enschede
2025-11-13
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-netherlands

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,174 studies in total at the last sync on 16 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Netherlands?

1 of the 1 studies on this page are recruiting new participants as of the 16 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 1 studies
PhaseStudiesRecruitingShare
Phase 311100%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Marieke Goodijk11

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Melanoma (Skin Cancer) (1)
→

Browse trials by site location

's-Hertogenbosch (1) Alkmaar (1) Almere Stad (1) Amsterdam (1) Apeldoorn (1) Arnhem (1) Eindhoven (1) Enschede (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.